News Briefs Esperas partners in $7 mln investment in anti-cancer agent Kirk Falconer - 11 April 2016 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
